AML with AML1-ETO fusion gene had lower transcript levels than those without AML1-ETO fusion gene (456.58% [86.78%-1306.69%] vs 941.28% [67.87%-6630.48%], P=0.0037; Figure 1F). This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.